Which patients with lower respiratory tract infections need inpatient treatment? Perceptions of physicians, nurses, patients and relatives

[1]  M. Fine,et al.  Reasons why emergency department providers do not rely on the pneumonia severity index to determine the initial site of treatment for patients with pneumonia. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  T. Bregenzer,et al.  Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. , 2009, JAMA.

[3]  T. Bregenzer,et al.  Effect of procalcitonin-based guidelines compared with standard guidelines on antibiotic use in lower respiratory tract infections: the randomized-controlled multicenter ProHOSP trial , 2009, Critical Care.

[4]  M. Briel,et al.  Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. , 2008, Archives of internal medicine.

[5]  V. Entwistle,et al.  The information and support needs of patients discharged after a short hospital stay for treatment of low-risk Community Acquired Pneumonia: implications for treatment without admission , 2008, BMC pulmonary medicine.

[6]  J. Maurer.  Factors Associated with the Hospitalization of Low-risk Patients with Community-acquired Pneumonia in a Cluster-Randomized Trial , 2008 .

[7]  T. Bregenzer,et al.  Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial , 2007, BMC Health Services Research.

[8]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  M. Christ-Crain,et al.  Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. , 2007, Chest.

[10]  M. Christ-Crain,et al.  Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. , 2006, American journal of respiratory and critical care medicine.

[11]  M. Fine,et al.  Factors associated with the hospitalization of low-risk patients with community-acquired pneumonia in a cluster-randomized trial , 2006, Journal of General Internal Medicine.

[12]  M. Fine,et al.  Effect of Increasing the Intensity of Implementing Pneumonia Guidelines , 2005, Annals of Internal Medicine.

[13]  A. Torres,et al.  Guidelines for the management of adult lower respiratory tract infections , 2005, European Respiratory Journal.

[14]  A. Levy,et al.  Determinants of hospital length of stay among patients with pneumonia admitted to a large Canadian hospital from 1991 to 2001. , 2005, Canadian Respiratory Journal.

[15]  L. Mandell.  Decisions about Treating Community-Acquired Pneumonia , 2005, Annals of Internal Medicine.

[16]  T. Welte,et al.  CAPNETZ—Community-Acquired Pneumonia Competence Network , 2004, Infection.

[17]  M. Christ-Crain,et al.  Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial , 2004, The Lancet.

[18]  E. Martínez-Moragón,et al.  Duration of length of stay in pneumonia: influence of clinical factors and hospital type , 2003, European Respiratory Journal.

[19]  M. Aliyu,et al.  Determinants for hospitalization in " low-risk" community acquired pneumonia , 2003, BMC infectious diseases.

[20]  K. Ali,et al.  Infectious disease: #83 Low-risk community acquired pneumonia: Sociodemographic and clinical determinants for hospitalization , 2002 .

[21]  D. Postma,et al.  Chronic obstructive pulmonary disease. , 2002, Clinical evidence.

[22]  M. Fine,et al.  Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. , 2001, American journal of respiratory and critical care medicine.

[23]  Henry Mintzberg,et al.  Managing the care of health and the cure of disease--Part I: Differentiation. , 2001, Health care management review.

[24]  Henry Mintzberg,et al.  Managing the care of health and the cure of disease--Part II: Integration. , 2001, Health care management review.

[25]  P. Barnes,et al.  Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[26]  R. Gonzales,et al.  Uncomplicated Acute Bronchitis , 2000, Annals of Internal Medicine.

[27]  I. Bolíbar,et al.  Epidemiology of community-acquired pneumonia in adults: a population-based study. , 2000, The European respiratory journal.

[28]  T. Marrie,et al.  A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. , 2000, JAMA.

[29]  M. Niederman,et al.  The cost of treating community-acquired pneumonia. , 1998, Clinical therapeutics.

[30]  M. Fine,et al.  A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.

[31]  A. Detsky,et al.  Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia. , 1996, Archives of internal medicine.

[32]  L. McMahon,et al.  Variation in Hospital Admissions Among Small Areas: A Comparison of Maine and Michigan , 1989, Medical care.

[33]  John E. Wennberg,et al.  Using diagnosis-related groups for studying variations in hospital admissions , 1988, Health care financing review.